-
Je něco špatně v tomto záznamu ?
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data
A. Slioui, G. Tammam, F. Vanoli, AD. Marina, S. Vohanka, NE. Gilhus, I. Moroni, MI. Leite, F. Piehl, C. Antozzi, J. Pini, F. Stascheit, S. Attarian, E. Santos, J. Verschuuren, L. Canonge, J. Garcia, C. Perriard, E. Cortés-Vicente, R. Mantegazza,...
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
BioMedCentral
od 2006-12-01
BioMedCentral Open Access
od 2006
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
Springer Nature OA/Free Journals
od 2006-12-01
- MeSH
- delfská metoda * MeSH
- konsensus MeSH
- lidé MeSH
- myasthenia gravis * terapie diagnóza MeSH
- registrace * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: Myasthenia gravis (MG) is a rare autoimmune disorder. Several new treatment concepts have emerged in recent years, but access to these treatments varies due to differing national reimbursement regulations, leading to disparities across Europe. This highlights the need for high-quality data collection by stakeholders to establish MG registries. A European MG registry could help bridge the treatment access gap across different countries, offering critical data to support regulatory decisions, foster international collaborations, and enhance clinical and epidemiological research. Several national MG registries already exist or are in development. To avoid duplication and ensure harmonization in data collection, a modified Delphi procedure was implemented to identify essential data elements for inclusion in national registries. RESULTS: Following a literature review, consultations with patient associations and pharmaceutical companies, and input from multiple European MG experts, 100 data elements were identified. Of these, 62 reached consensus for inclusion and classification, while only 1 item was agreed for exclusion. 30 items failed to reach the ≥ 80% agreement threshold and were excluded. Among the 62 accepted items, 21 were classified as mandatory data elements, 32 optional, and 9 items pertained to the informed consent form. CONCLUSIONS: Through a modified Delphi procedure, consensus was successfully achieved. This consensus-based approach represents a crucial step toward harmonizing MG registries across Europe. The resulting dataset will facilitate the sharing of knowledge and enhance European collaborations. Furthermore, the harmonized data may assist in regulatory or reimbursement decisions regarding novel therapies, as well as address treatment access disparities between European countries.
Department of Brain and Behavioral Sciences University of Pavia IRCCS Mondino Foundation Pavia Italy
Department of Clinical Medicine University of Bergen Bergen Norway
Department of Human Neurosciences Sapienza University of Rome Rome Italy
Department of Neurology Faculty of Medicine University Hospital Brno Masaryk University Brno Czechia
Department of Neurology Leiden University Medical Center Leiden the Netherlands
Department of Pediatric Neurosciences Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
ESIEE PARIS School Gustave Eiffel University Paris France
Neurology Department Centro Hospitalar Universitário de Santo António
Neuromuscular Diseases Unit Hospital de La Santa Creu 1 Sant Pau Barcelona Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009515
- 003
- CZ-PrNML
- 005
- 20250429135130.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13023-024-03520-3 $2 doi
- 035 __
- $a (PubMed)40069719
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Slioui, Abderhmane $u Peripheral Nervous System and Muscle Department, Reference Center for Neuromuscular Disorders, Pasteur 2 Hospital, Centre Hospitalier, Universitaire de Nice, Nice University Hospital, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France
- 245 10
- $a Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data / $c A. Slioui, G. Tammam, F. Vanoli, AD. Marina, S. Vohanka, NE. Gilhus, I. Moroni, MI. Leite, F. Piehl, C. Antozzi, J. Pini, F. Stascheit, S. Attarian, E. Santos, J. Verschuuren, L. Canonge, J. Garcia, C. Perriard, E. Cortés-Vicente, R. Mantegazza, A. Meisel, S. Sacconi
- 520 9_
- $a BACKGROUND: Myasthenia gravis (MG) is a rare autoimmune disorder. Several new treatment concepts have emerged in recent years, but access to these treatments varies due to differing national reimbursement regulations, leading to disparities across Europe. This highlights the need for high-quality data collection by stakeholders to establish MG registries. A European MG registry could help bridge the treatment access gap across different countries, offering critical data to support regulatory decisions, foster international collaborations, and enhance clinical and epidemiological research. Several national MG registries already exist or are in development. To avoid duplication and ensure harmonization in data collection, a modified Delphi procedure was implemented to identify essential data elements for inclusion in national registries. RESULTS: Following a literature review, consultations with patient associations and pharmaceutical companies, and input from multiple European MG experts, 100 data elements were identified. Of these, 62 reached consensus for inclusion and classification, while only 1 item was agreed for exclusion. 30 items failed to reach the ≥ 80% agreement threshold and were excluded. Among the 62 accepted items, 21 were classified as mandatory data elements, 32 optional, and 9 items pertained to the informed consent form. CONCLUSIONS: Through a modified Delphi procedure, consensus was successfully achieved. This consensus-based approach represents a crucial step toward harmonizing MG registries across Europe. The resulting dataset will facilitate the sharing of knowledge and enhance European collaborations. Furthermore, the harmonized data may assist in regulatory or reimbursement decisions regarding novel therapies, as well as address treatment access disparities between European countries.
- 650 12
- $a myasthenia gravis $x terapie $x diagnóza $7 D009157
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a registrace $7 D012042
- 650 12
- $a delfská metoda $7 D003697
- 650 _2
- $a konsensus $7 D032921
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tammam, Giulia $u Peripheral Nervous System and Muscle Department, Reference Center for Neuromuscular Disorders, Pasteur 2 Hospital, Centre Hospitalier, Universitaire de Nice, Nice University Hospital, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France $u Department of Brain and Behavioral Sciences, University of Pavia, IRCCS Mondino Foundation, Pavia, Italy
- 700 1_
- $a Vanoli, Fiammetta $u Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy $u Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy
- 700 1_
- $a Marina, Adela Della $u Department of Pediatric Neurology, Centre for Neuromuscular Disorders, C-TNBS, University Duisburg-Essen, Essen, Germany
- 700 1_
- $a Vohanka, Stanislav $u Department of Neurology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czechia
- 700 1_
- $a Gilhus, Nils Erik $u Department of Clinical Medicine, University of Bergen, Bergen, Norway
- 700 1_
- $a Moroni, Isabella $u Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- 700 1_
- $a Leite, Maria Isabel $u Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK
- 700 1_
- $a Piehl, Fredrik $u Departments of Clinical Neuroscience, Karolinska Institutet, and Neurology, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Antozzi, Carlo $u Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy $u Immunotherapy and Apheresis Departmental Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- 700 1_
- $a Pini, Jonathan $u Peripheral Nervous System and Muscle Department, Reference Center for Neuromuscular Disorders, Pasteur 2 Hospital, Centre Hospitalier, Universitaire de Nice, Nice University Hospital, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France
- 700 1_
- $a Stascheit, Frauke $u Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Department of Neurology With Experimental Neurologie, Neuroscience Clinical Research Center, Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany
- 700 1_
- $a Attarian, Shahram $u Reference Center for Neuromuscular Disorders and ALS, Timone University Hospital, Aix-Marseille University, Marseille, France
- 700 1_
- $a Santos, Ernestina $u Neurology Department, Centro Hospitalar Universitário de Santo António; Unit for Multidisciplinary Research in Biomedicine, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
- 700 1_
- $a Verschuuren, Jan $u Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
- 700 1_
- $a Canonge, Lou $u Peripheral Nervous System and Muscle Department, Reference Center for Neuromuscular Disorders, Pasteur 2 Hospital, Centre Hospitalier, Universitaire de Nice, Nice University Hospital, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France $u ESIEE PARIS School, Gustave Eiffel University, Paris, France
- 700 1_
- $a Garcia, Jeremy $u Peripheral Nervous System and Muscle Department, Reference Center for Neuromuscular Disorders, Pasteur 2 Hospital, Centre Hospitalier, Universitaire de Nice, Nice University Hospital, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France
- 700 1_
- $a Perriard, Caroline $u Reference Center for Neuromuscular Disorders, Lenval Pediatric Hospitals of Nice University Hospital, Nice, France
- 700 1_
- $a Cortés-Vicente, Elena $u Neuromuscular Diseases Unit, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain
- 700 1_
- $a Mantegazza, Renato $u Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- 700 1_
- $a Meisel, Andreas $u Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Department of Neurology With Experimental Neurologie, Neuroscience Clinical Research Center, Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany
- 700 1_
- $a Sacconi, Sabrina $u Peripheral Nervous System and Muscle Department, Reference Center for Neuromuscular Disorders, Pasteur 2 Hospital, Centre Hospitalier, Universitaire de Nice, Nice University Hospital, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France. sacconi.s@chu-nice.fr $u Institute for Research On Cancer and Aging of Nice, CNRS, INSERM, Côte d'Azur University, SNPM - Hôpital Pasteur 2 - 30 voie Romaine, 06001, Nice CEDEX, France. sacconi.s@chu-nice.fr $1 https://orcid.org/0000000202461455
- 773 0_
- $w MED00165365 $t Orphanet journal of rare diseases $x 1750-1172 $g Roč. 20, č. 1 (2025), s. 115
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40069719 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135126 $b ABA008
- 999 __
- $a ok $b bmc $g 2311103 $s 1246596
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 20 $c 1 $d 115 $e 20250311 $i 1750-1172 $m Orphanet journal of rare diseases $n Orphanet J Rare Dis $x MED00165365
- LZP __
- $a Pubmed-20250415
